Financhill
Sell
39

GRMN Quote, Financials, Valuation and Earnings

Last price:
$204.88
Seasonality move :
2.14%
Day range:
$202.60 - $205.77
52-week range:
$169.26 - $261.69
Dividend yield:
1.68%
P/E ratio:
25.26x
P/S ratio:
5.72x
P/B ratio:
4.65x
Volume:
288.5K
Avg. volume:
1.1M
1-year change:
-2.85%
Market cap:
$39.4B
Revenue:
$6.3B
EPS (TTM):
$8.11

Earnings Data

Next earnings date for GRMN
Feb 18
2026
Most recent earnings per share
$2.08
Beat by $0.09
(Oct 29/2025)
Consensus Estimate
$1.99
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GRMN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/18/2026 Q4 $2B -- -- $2.39 --
10/29/2025 Q3 $1.8B $1.8B $2.08 $1.99 $0.09
07/30/2025 Q2 $1.7B $1.8B $2.07 $1.90 $0.18
04/30/2025 Q1 $1.5B $1.5B $1.72 $1.68 $0.04
02/19/2025 Q4 $1.7B $1.8B $2.25 $2.02 $0.23
10/30/2024 Q3 $1.4B $1.6B $2.07 $1.45 $0.62
07/31/2024 Q2 $1.4B $1.5B $1.56 $1.44 $0.12
05/01/2024 Q1 $1.3B $1.4B $1.43 $1.01 $0.42
02/21/2024 Q4 $1.4B $1.5B $2.82 $1.40 $1.41
11/01/2023 Q3 $1.2B $1.3B $1.34 $1.28 $0.06
08/02/2023 Q2 -- $1.3B $1.50 -- --
05/03/2023 Q1 -- $1.1B $1.05 -- --
02/22/2023 Q4 -- $1.3B $1.53 -- --
10/26/2022 Q3 -- $1.1B $1.09 -- --
07/27/2022 Q2 -- $1.2B $1.33 -- --
04/27/2022 Q1 -- $1.2B $1.09 -- --
02/16/2022 Q4 -- $1.4B $1.48 -- --
10/27/2021 Q3 -- $1.2B $1.34 -- --
07/28/2021 Q2 -- $1.3B $1.64 -- --
04/28/2021 Q1 -- $1.1B $1.14 -- --
02/17/2021 Q4 -- $1.4B $1.73 -- --
10/28/2020 Q3 -- $1.1B $1.63 -- --
07/29/2020 Q2 -- $869.9M $0.96 -- --
04/29/2020 Q1 -- $856.1M $0.84 -- --
02/19/2020 Q4 -- $1.1B $1.89 -- --
10/30/2019 Q3 -- $934.4M $1.19 -- --
07/31/2019 Q2 -- $954.8M $1.17 -- --
05/01/2019 Q1 -- $766.1M $0.74 -- --
02/20/2019 Q4 -- $932.1M $1.00 -- --
10/31/2018 Q3 -- $810M $0.97 -- --
08/01/2018 Q2 -- $894.5M $1.00 -- --
05/02/2018 Q1 -- $710.9M $0.68 -- --
02/21/2018 Q4 -- $897.3M $0.75 -- --
11/01/2017 Q3 -- $751.2M $0.80 -- --
08/02/2017 Q2 -- $831.5M $0.94 -- --
05/03/2017 Q1 -- $641.5M $1.26 -- --
02/22/2017 Q4 -- $860.8M $0.72 -- --
10/26/2016 Q3 -- $722.3M $0.66 -- --
07/27/2016 Q2 -- $811.6M $0.85 -- --
04/27/2016 Q1 -- $624M $0.46 -- --
02/17/2016 Q4 -- $781.4M $0.70 -- --

Garmin Ltd. Earnings Questions

  • How Much did Garmin Ltd. Generate in Revenue Last Quarter?

    Garmin Ltd. reported $1.8B worth of top line sales in its most recent quarter.

  • Did Garmin Ltd. Beat Earnings Last Quarter?

    Garmin Ltd. announced earnings per share of $2.08 which represents a beat of analyst forecast a $1.99 per share.

  • Is Garmin Ltd. Profitable?

    Garmin Ltd. reported $1B that represents $5.41 per share over the last quarter.

  • What is the Analyst Consensus for Garmin Ltd. EPS Next Year?

    Garmin Ltd.'s earnings are forecast to grow from $7.30 per share to $7.02 per share next year representing an increase of 12.02%.

  • When is Garmin Ltd.'s Earnings Date?

    Garmin Ltd.'s next earnings date is February 18, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock